Camden Capital, LLC Exact Sciences Corp Transaction History

Camden Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$62.68 - $95.05 $22,627 - $34,313	-361 Reduced 11.85%	2,685 $252,000
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $143,740 - $215,565	3,046 New	3,046 $206,000
Q2 2022 Aug 03, 2022	SELL	$35.61 - $76.23 $113,809 - $243,631	-3,196 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$57.56 - $82.54 $35,284 - $50,597	613 Added 23.73%	3,196 $223,000
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $23,417 - $32,519	323 Added 14.29%	2,583 $201,000
Q3 2021 Nov 03, 2021	BUY	$90.24 - $124.05 $45,661 - $62,769	506 Added 28.85%	2,260 $216,000
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $11,426 - $16,990	122 Added 7.48%	1,754 $218,000
Q1 2021 May 10, 2021	SELL	$116.57 - $155.01 $233 - $310	-2 Reduced 0.12%	1,632 $215,000
Q4 2020 Feb 04, 2021	BUY	$99.61 - $142.12 $162,762 - $232,224	1,634 New	1,634 $216,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Camden Capital, LLC with notifications on news.